Company intelligence / Profile preview

Royal GD

Deventer, Overijssel, Netherlandsgdanimalhealth.com ↗

Ownership: Private
Employees: ~400
Development stage: Commercial

Overview

Royal GD operates one of the largest veterinary laboratories globally with nearly 5 million analyses annually. It provides contract research, disease monitoring programs for governments and industry partners worldwide. The organization has over a century of experience in animal health management and diagnostics. No clinical trial results as it does not develop drugs or biologics for human use.

Therapeutic areas: OtherInfectious Diseases
Modalities: Diagnostic assays (including molecular diagnostics)Veterinary laboratory services
Industry: Veterinary

Partnerships

Alveo Technologies (collaboration on rapid molecular diagnostics)Dutch government agencies for national animal disease surveillance programsEuropean Commission/Horizon2020 projects participation

Beyond the preview

Go deeper on Royal GD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Royal GD.

Explore the full profile